Welcome! In order to carry out this action, you must be signed in with your FinBrowser
account. No account yet? No problem! Creating a new one is a breeze and will only take a minute of
your time.
Hey there! Due to the recent policy changes implemented by Twitter, I regret to inform you that
FinBrowser is currently unable to display any new Tweets. I know this might be disappointing, as
Twitter
is a valuable source of information and updates for many of us. However, I want to assure you that I
am
actively working on finding alternative solutions and exploring ways to reintegrate Twitter sources
into
this website. I appreciate your patience and understanding during this time of transition.
$LVTX the ongoing clinical trial of LAVA-051 targeting CD1d expressing hematological tumors, including multiple myeloma (MM), chronic lymphocytic leukemia (CLL) and AML will be discontinued
$PDSB Announces Achievement of Efficacy Threshold in Stage 2 of the VERSATILE-002 Trial Evaluating PDS0101 and KEYTRUDA in Head and Neck Cancer.
14 patients in the immune checkpoint inhibitor naïve arm of VERSATILE-002 have experienced either a CR or PR on two consecutive scans,…
$TSVT Announces Clinical Study Pause of PLAT-08 Trial of SC-DARIC33 in AML.
The pause was instituted as part of the clinical study protocol stopping rules in response to a recent Grade 5 (fatal) serious adverse event (SAE)
$ABEO FDA requested additional assay data to establish comparability between RVV sourced from Indiana University and RVV manufactured in-house at Abeona.
Co. has requested the pre-BLA meeting date for EB-101 be rescheduled for August.
Expects to file BLA for EB-101 in Q3